DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
” - 2 Robert Wood - 2 Xolair - 2 Wood - 2 Sharon Chinthrajah - 1 “ - 1 ” Xolair - 1 ” Wood - 1
Top related locs:
anaphylaxis Eudowood Johns University of South Florida Tampa U.S
Top related orgs:
Genentech - 2 FDA - 2 National Institutes of Health - 2 CNN - 1 New England - 1 of Medicine - 1 US Food and Drug Administration - 1 Stanford University - 1

Search resuls for: "Johns Hopkins Children’s Center"


2 mentions found


☆ New data shows asthma medicine may help reduce severe reactions in people with multiple food allergies
  + stars: | 2024-02-25 | by ( Amanda Musa | ) edition.cnn.com   time to read: +9 min
CNN —A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods. There is no cure for food allergies, and the only other FDA-approved treatment is Palforzia, an oral immunotherapy for peanut allergies in children between 4 and 17 years old. “But the reality is that most of our patients don’t just have peanut allergy,” Wood added. For people who have multiple severe food allergies and even moderate to severe allergic asthma, Casale says, Xolair might be the best treatment option. Xolair does not eliminate food allergies, and unlike with some environmental allergies such as pollen, many people never outgrow them, Casale added.
Persons: ”, Sharon Chinthrajah, “, ” Xolair, Robert Wood, ” Wood, Xolair, Wood, omalizumab, Thomas Casale, Palforzia, Casale, they’ve, ” Lindsey Mathias, Dr, Sanjay Gupta, Chinthrajah, “ We’re Organizations: CNN, New England, of Medicine, US Food and Drug Administration, Stanford University, of Allergy, Immunology, Johns Hopkins Children’s, Genentech, Novartis, FDA, National Institutes of Health, University of South, American Academy of Allergy Asthma, CNN Health, Xolair Locations: anaphylaxis, Eudowood, Johns, University of South Florida Tampa
☆ FDA Expands Use of Asthma Drug Xolair to Treat Severe Food Allergies
  + stars: | 2024-02-16 | by ( Associated Press | Feb. | At P.M. | ) www.usnews.com   time to read: +3 min
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug omalizumab, became the first medication approved to reduce allergic reactions caused by accidental exposure to food triggers. An estimated 17 million people in the U.S. have the type of food allergies that can cause rapid, serious symptoms, including severe, whole-body reactions that are potentially deadly. Wood estimated that 25% to 50% of people with food allergies, particularly children and young adults, would elect to use Xolair. The drug has been used “off-label” to treat food allergies, said Dr. Ruchi Gupta, director of the Center for Food Allergy & Asthma Research at Northwestern University.
Persons: Xolair, ”, Robert Wood, Wood, Ruchi Gupta Organizations: U.S . Food, Drug Administration, Johns Hopkins Children’s Center, FDA, National Institutes of Health, Center for Food Allergy, Asthma Research, Northwestern University, drugmakers Novartis, Roche, Genentech, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: U.S
0 next >>
Total: 2